Kardiális reszinkronizációs terápia pitvarfibrilláló betegekben

Translated title of the contribution: Cardiac resynchronization therapy for patients with atrial fibrillation

Attila Mihálcz, Pál Ábrahám, A. Kardos, Csaba Földesi, Tamás Szili-Török

Research output: Contribution to journalArticle

Abstract

Atrial fibrillation and chronic heart failure are two major and even growing cardiovascular conditions that often coexist. Cardiac resynchronization therapy is an important, device-based, non-pharmacological approach in a selected group of chronic heart failure patients that has been shown to improve left ventricular function and to reduce both morbidity and mortality in large randomized trials. The latest European and American guidelines have considered atrial fibrillation patients with heart failure eligible for cardiac resynchronization therapy. This review summarizes current literature concerning the following topics: prognostic relevance of atrial fibrillation in heart failure, effects of cardiac resynchronization therapy in atrial fibrillation, relevance and strategies of rhythm and rate control in this group of patients. Authors explain how atrial fibrillation may interfere with the delivery of adequate cardiac resynchronization therapy, how to reduce the burden of atrial tachyarrhythmias, and finally present a brief overview.

Original languageHungarian
Pages (from-to)1757-1763
Number of pages7
JournalOrvosi Hetilap
Volume152
Issue number44
DOIs
Publication statusPublished - Oct 1 2011

Fingerprint

Cardiac Resynchronization Therapy
Atrial Fibrillation
Heart Failure
Left Ventricular Function
Tachycardia
Guidelines
Morbidity
Equipment and Supplies
Control Groups
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mihálcz, A., Ábrahám, P., Kardos, A., Földesi, C., & Szili-Török, T. (2011). Kardiális reszinkronizációs terápia pitvarfibrilláló betegekben. Orvosi Hetilap, 152(44), 1757-1763. https://doi.org/10.1556/OH.2011.29204

Kardiális reszinkronizációs terápia pitvarfibrilláló betegekben. / Mihálcz, Attila; Ábrahám, Pál; Kardos, A.; Földesi, Csaba; Szili-Török, Tamás.

In: Orvosi Hetilap, Vol. 152, No. 44, 01.10.2011, p. 1757-1763.

Research output: Contribution to journalArticle

Mihálcz, A, Ábrahám, P, Kardos, A, Földesi, C & Szili-Török, T 2011, 'Kardiális reszinkronizációs terápia pitvarfibrilláló betegekben', Orvosi Hetilap, vol. 152, no. 44, pp. 1757-1763. https://doi.org/10.1556/OH.2011.29204
Mihálcz A, Ábrahám P, Kardos A, Földesi C, Szili-Török T. Kardiális reszinkronizációs terápia pitvarfibrilláló betegekben. Orvosi Hetilap. 2011 Oct 1;152(44):1757-1763. https://doi.org/10.1556/OH.2011.29204
Mihálcz, Attila ; Ábrahám, Pál ; Kardos, A. ; Földesi, Csaba ; Szili-Török, Tamás. / Kardiális reszinkronizációs terápia pitvarfibrilláló betegekben. In: Orvosi Hetilap. 2011 ; Vol. 152, No. 44. pp. 1757-1763.
@article{ac69264c480f4bed9aeea3882ecdee8d,
title = "Kardi{\'a}lis reszinkroniz{\'a}ci{\'o}s ter{\'a}pia pitvarfibrill{\'a}l{\'o} betegekben",
abstract = "Atrial fibrillation and chronic heart failure are two major and even growing cardiovascular conditions that often coexist. Cardiac resynchronization therapy is an important, device-based, non-pharmacological approach in a selected group of chronic heart failure patients that has been shown to improve left ventricular function and to reduce both morbidity and mortality in large randomized trials. The latest European and American guidelines have considered atrial fibrillation patients with heart failure eligible for cardiac resynchronization therapy. This review summarizes current literature concerning the following topics: prognostic relevance of atrial fibrillation in heart failure, effects of cardiac resynchronization therapy in atrial fibrillation, relevance and strategies of rhythm and rate control in this group of patients. Authors explain how atrial fibrillation may interfere with the delivery of adequate cardiac resynchronization therapy, how to reduce the burden of atrial tachyarrhythmias, and finally present a brief overview.",
keywords = "atrial fibrillation, biventricular pacing, cardiac resynchronization therapy",
author = "Attila Mih{\'a}lcz and P{\'a}l {\'A}brah{\'a}m and A. Kardos and Csaba F{\"o}ldesi and Tam{\'a}s Szili-T{\"o}r{\"o}k",
year = "2011",
month = "10",
day = "1",
doi = "10.1556/OH.2011.29204",
language = "Hungarian",
volume = "152",
pages = "1757--1763",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "44",

}

TY - JOUR

T1 - Kardiális reszinkronizációs terápia pitvarfibrilláló betegekben

AU - Mihálcz, Attila

AU - Ábrahám, Pál

AU - Kardos, A.

AU - Földesi, Csaba

AU - Szili-Török, Tamás

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Atrial fibrillation and chronic heart failure are two major and even growing cardiovascular conditions that often coexist. Cardiac resynchronization therapy is an important, device-based, non-pharmacological approach in a selected group of chronic heart failure patients that has been shown to improve left ventricular function and to reduce both morbidity and mortality in large randomized trials. The latest European and American guidelines have considered atrial fibrillation patients with heart failure eligible for cardiac resynchronization therapy. This review summarizes current literature concerning the following topics: prognostic relevance of atrial fibrillation in heart failure, effects of cardiac resynchronization therapy in atrial fibrillation, relevance and strategies of rhythm and rate control in this group of patients. Authors explain how atrial fibrillation may interfere with the delivery of adequate cardiac resynchronization therapy, how to reduce the burden of atrial tachyarrhythmias, and finally present a brief overview.

AB - Atrial fibrillation and chronic heart failure are two major and even growing cardiovascular conditions that often coexist. Cardiac resynchronization therapy is an important, device-based, non-pharmacological approach in a selected group of chronic heart failure patients that has been shown to improve left ventricular function and to reduce both morbidity and mortality in large randomized trials. The latest European and American guidelines have considered atrial fibrillation patients with heart failure eligible for cardiac resynchronization therapy. This review summarizes current literature concerning the following topics: prognostic relevance of atrial fibrillation in heart failure, effects of cardiac resynchronization therapy in atrial fibrillation, relevance and strategies of rhythm and rate control in this group of patients. Authors explain how atrial fibrillation may interfere with the delivery of adequate cardiac resynchronization therapy, how to reduce the burden of atrial tachyarrhythmias, and finally present a brief overview.

KW - atrial fibrillation

KW - biventricular pacing

KW - cardiac resynchronization therapy

UR - http://www.scopus.com/inward/record.url?scp=80054679455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054679455&partnerID=8YFLogxK

U2 - 10.1556/OH.2011.29204

DO - 10.1556/OH.2011.29204

M3 - Article

C2 - 21997580

AN - SCOPUS:80054679455

VL - 152

SP - 1757

EP - 1763

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 44

ER -